Back to Search Start Over

Role of Age, Fitness and Concomitant Medications in CLL Patients Treated with Venetoclax

Authors :
Frustaci, Anna Maria
Biagi, Annalisa
Chiarenza, Annalisa
Coscia, Marta
Ciolli, Stefania
Laurenti, Luca
Sportoletti, Paolo
Reda, Gianluigi
Varettoni, Marzia
Mauro, Francesca Romana
Murru, Roberta
Baratè, Claudia
Greco, Antonino
Borella, Chiara
Zamprogna, Giulia
Martino, Enrica Antonia
Vitale, Candida
Morelli, Francesca
Fresa, Alberto
Guarente, Valerio
Noto, Alessandro
Postorino, Massimiliano
Cairoli, Roberto
Montillo, Marco
Del Poeta, Giovanni
Tedeschi, Alessandra
Source :
Blood; November 2020, Vol. 136 Issue: Supplement 1 p25-26, 2p
Publication Year :
2020

Abstract

Coscia: Abbvie: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Shire: Honoraria, Membership on an entity's Board of Directors or advisory committees; Gilead: Honoraria, Membership on an entity's Board of Directors or advisory committees; Karyopharm Therapeutics: Research Funding. Ciolli:Abbvie: Research Funding; Janssen: Honoraria. Laurenti:Janssen: Honoraria; Gilead: Honoraria; AbbVie: Honoraria; Roche: Honoraria. Sportoletti:AbbVie: Honoraria; Janssen: Honoraria. Reda:Janssen: Membership on an entity's Board of Directors or advisory committees; Gilead: Membership on an entity's Board of Directors or advisory committees; Abbvie: Membership on an entity's Board of Directors or advisory committees. Varettoni:Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: Travel/accommodations/expenses; Roche: Consultancy, Membership on an entity's Board of Directors or advisory committees; AbbVie: Other: Travel/accommodations/expenses. Mauro:Abbvie: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Astrazeneca: Membership on an entity's Board of Directors or advisory committees; Jannsen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Octopharma: Consultancy; Shire-Takeda: Membership on an entity's Board of Directors or advisory committees. Murru:Abbvie: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Gilead: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Vitale:Janssen: Honoraria. Montillo:Gilead: Honoraria, Speakers Bureau; Verastem: Honoraria; Astra Zeneca: Honoraria; Janssen: Honoraria, Speakers Bureau; AbbVie: Honoraria, Speakers Bureau; F. Hoffmann-La Roche: Honoraria, Research Funding. Tedeschi:Janssen: Honoraria, Speakers Bureau; Acerta: Honoraria, Speakers Bureau; Sunesis: Honoraria, Speakers Bureau; Beigene: Honoraria, Speakers Bureau; Abbvie: Honoraria, Speakers Bureau.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
136
Issue :
Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs54548292
Full Text :
https://doi.org/10.1182/blood-2020-137202